Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06851988 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients

StatusRecruiting
PhaseNot applicable
Started2023-05-03
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Oct 30, 2025 → Oct 30, 2026
Primary endpoints added 8 → 12 primary endpoints
See other at-risk trials from Chang Gung Memorial Hospital

Amendment history

2026-09-25
Primary endpoint(s) modified8 to 12 entries
Was% of participants with phenoage and age, % of participants with phenoage and age, Peak VO2 (ml/min/kg) of participants, Peak VO2 (ml/min/kg) of participants, Peak VO2 (ml/min/kg) of participants, Questionnaire of European Organisation for Research and Treatment of Cancer Quality of Life Head and Neck Module (EORTC QLQ-HN43), Questionnaire of European Organisation for Research and Treatment of Cancer Quality of Life Head and Neck Module (EORTC QLQ-HN43), Questionnaire of European Organisation for Research and Treatment of Cancer Quality of Life Head and Neck Module (EORTC QLQ-HN43)
NowPeak VO2 (ml/min/kg) of participants, Peak VO2 (ml/min/kg) of participants, Peak VO2 (ml/min/kg) of participants, Peak VO2 (ml/min/kg) of participants, Questionnaire of European Organisation for Research and Treatment of Cancer Quality of Life Head and Neck Module (EORTC QLQ-HN43), Questionnaire of European Organisation for Research and Treatment of Cancer Quality of Life Head and Neck Module (EORTC QLQ-HN43), Questionnaire of European Organisation for Research and Treatment of Cancer Quality of Life Head and Neck Module (EORTC QLQ-HN43), Questionnaire of European Organisation for Research and Treatment of Cancer Quality of Life Head and Neck Module (EORTC QLQ-HN43), percent of participants with phenoage and age, percent of participants with phenoage and age, percent of participants with phenoage and age, percent of participants with phenoage and age
Enrollment increased: 180 → 290 participants
Trial arms changed: 2 → 4
Primary completion pushed: 2025-10-30 → 2026-10-30
Completion moved earlier: 2027-10-30 → 2026-10-30
Through the implementation of this three-year project, investigators expect to find a safe and effective exercise prescription for patients with oral cancer after surgery. The findings will encourage and promise and add further support to the concept that exercise prescription is worth implementation as part of care for the patients with head and neck cancer.
Trial Details
NCT Number NCT06851988
Lead Sponsor Chang Gung Memorial Hospital
Conditions Aging, High-intensity Interval Training, Head and Neck Cancers - Tonsils
Enrollment 290 participants
Start Date 2023-05-03
Primary Completion 2026-10-30 (estimated)
Study Completion 2026-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-09-24